Package 43068-304-06

Brand: hetlioz lq

Generic: tasimelteon
NDC Package

Package Facts

Identity

Package NDC 43068-304-06
Digits Only 4306830406
Product NDC 43068-304
Description

1 BOTTLE in 1 CARTON (43068-304-06) / 158 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2020-12-10
Brand hetlioz lq
Generic tasimelteon
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3248eef5-6bad-4844-a6f9-2f5fddd39c8d", "openfda": {"nui": ["N0000175743", "N0000000250"], "unii": ["SHS4PU80D9"], "rxcui": ["1490473", "1491624", "2468312", "2468316"], "spl_set_id": ["ca4a9b63-708e-49e9-8f9b-010625443b90"], "pharm_class_epc": ["Melatonin Receptor Agonist [EPC]"], "pharm_class_moa": ["Melatonin Receptor Agonists [MoA]"], "manufacturer_name": ["Vanda Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (43068-304-02)  / 48 mL in 1 BOTTLE", "package_ndc": "43068-304-02", "marketing_start_date": "20201210"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (43068-304-06)  / 158 mL in 1 BOTTLE", "package_ndc": "43068-304-06", "marketing_start_date": "20201210"}], "brand_name": "Hetlioz LQ", "product_id": "43068-304_3248eef5-6bad-4844-a6f9-2f5fddd39c8d", "dosage_form": "SUSPENSION", "pharm_class": ["Melatonin Receptor Agonist [EPC]", "Melatonin Receptor Agonists [MoA]"], "product_ndc": "43068-304", "generic_name": "tasimelteon", "labeler_name": "Vanda Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hetlioz", "brand_name_suffix": "LQ", "active_ingredients": [{"name": "TASIMELTEON", "strength": "4 mg/mL"}], "application_number": "NDA214517", "marketing_category": "NDA", "marketing_start_date": "20201210", "listing_expiration_date": "20261231"}